ACUTE MYELOID LEUKAEMIA

Clinical trials for ACUTE MYELOID LEUKAEMIA explained in plain language.

Never miss a new study

Get alerted when new ACUTE MYELOID LEUKAEMIA trials appear

Sign up with your email to follow new studies for ACUTE MYELOID LEUKAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 2 Completed 1 Terminated 1

Generic azacitidine tablet tested against Brand-Name onureg in AML patients

Disease control Completed

This study compared a generic azacitidine tablet to the brand-name drug Onureg in 32 adults with acute myeloid leukemia (AML) who are in remission. Participants took a single dose of each drug under fasting conditions to see if the generic version is absorbed similarly. The goal …

Matched conditions: ACUTE MYELOID LEUKAEMIA

Phase: PHASE1 • Sponsor: Hikma Pharmaceuticals LLC • Aim: Disease control

Last updated Jun 27, 2026 07:52 UTC

ACUTE MYELOID LEUKAEMIA

Get alerted when new ACUTE MYELOID LEUKAEMIA trials appear

Generic azacitidine tablet tested against Brand-Name onureg in AML patients